Unveiled at BioTechX Europe 2025, the brand new options are purpose-built to speed up analysis, scientific trial design and regulatory processes.
Professional.ai, a number one supplier of enterprise synthetic intelligence options for enterprise worth creation, introduced the debut of its new AI-powered choices designed to speed up innovation throughout the pharmaceutical, healthcare and life sciences industries. Launched at BioTechX Europe 2025, Europe’s largest congress devoted to pharma & healthcare, the brand new options allow organizations to reinforce knowledge evaluation, streamline discovery processes and unlock new potentialities for scientific trials and therapeutic enchancment:
EIX-Submission Readiness empowers groups to construct smarter, extra environment friendly workflows for regulatory documentation.
EIX-Preclinical Doc Intelligence streamlines preclinical documentation with larger pace and accuracy, releasing consultants to deal with innovation.
EIX-Scientific Trials Intelligence helps analysis groups to distill probably the most correct, up-to-date info by disambiguating throughout mountains of content material from scientific registries, scientific publications and real-world knowledge.
EIX-IP Detection delivers complete, explainable insights throughout patents, scientific literature and scientific trial knowledge.
Additionally Learn: AiThority Interview with Tim Morrs, CEO at SpeakUp
Leveraging its deep area experience and distinctive hybrid AI method, Professional.ai helps researchers rework the complexity of analysis & growth into strategic benefit. By decreasing guide effort and scaling insights from huge volumes of information, the brand new options use the best AI strategies to make sure regulatory accuracy, enhance trial design, speed up affected person recruitment, cut back prices and decrease the fixed dangers of delays.
“We’re extraordinarily happy with this new providing for Pharma & Life Sciences, which represents a major development in our mission to harness AI for significant affect in these industries,” mentioned Christophe Aubry, World Head of Life Sciences & Healthcare, Professional.ai. “Our enhanced options are designed to cut back complexity, improve scientific and regulatory accuracy, and free consultants to deal with innovation the place it issues most. By bringing automation, explainability, and traceability to each step—from analysis documentation to submission readiness—we allow smarter, quicker, and compliant decision-making.”
With these improvements, Professional.ai continues to set the usual for making use of AI in Pharma & Life Sciences, delivering larger effectivity and reliability throughout the life sciences worth chain by way of clever doc automation and AI brokers.
Additionally Learn: Cognitive Product Design: Empowering Non-Technical Customers By Pure Language Interplay With AI-Native PLM
[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]
